Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer, which is difficult to treat and lacks a reliable prognostic marker. A previous study showed that the endoplasmic reticulum stress marker, glucose-regulated-protein-78 (GRP78), is a potential prognostic marker for ccRCC. The present study aimed to: (1) examine whether GRP78 was upregulated in ccRCC compared with matched non-neoplastic renal tissue; and (2) investigate whether GRP78 expression in ccRCC tissue or perinephric adipose tissue has any association with ccRCC aggressiveness.
A retrospective cross-sectional study of 267 patients who underwent nephrectomy for renal tumors between June 2013 and October 2017 was conducted at Princess Alexandra Hospital, Brisbane, Australia. Software-assisted quantification of average grey value of staining intensity (staining intensity method) and proportion of positive pixels (positive pixel method) was applied to measure expression of GRP78 in archived specimens of renal tumor tissues (n = 114), adjacent non-neoplastic renal tissues (n = 68), and perinephric adipose tissues (n = 60) in participants diagnosed with ccRCC.
GRP78 was not upregulated in renal tumor tissue compared with paired normal renal tissue. In tumor tissue, GRP78 expression did not show any association with ccRCC aggressiveness using either quantification method. In adipose tissue, downregulation of GRP78 demonstrated poor correlation with increased probability of metastasis, with one unit increase in average grey value of GRP78 staining weakly correlating with a 17% increase in the odds ratio of metastasis (95% confidence interval: 0.99 to 1.38, p = 0.07).
GRP78 is not valuable as a risk stratification marker for ccRCC.
PloS one. 2019 Jan 17*** epublish ***
Kunyu Shen, David A Vesey, Robert J Ellis, Sharon Juliet Del Vecchio, Yeoungjee Cho, Armando Teixeira-Pinto, Michael A McGuckin, David W Johnson, Glenda C Gobe
Centre for Kidney Disease Research, The University of Queensland, Brisbane, Australia., Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia., Centre for Kidney Research, Kids Research, Children's Hospital at Westmead, Westmead, Australia., Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, Melbourne, Australia.